+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "In Vitro Colorectal Cancer Screening Tests"

From
Global In-vitro Colorectal Cancer Screening Tests Market 2021-2025 - Product Thumbnail Image

Global In-vitro Colorectal Cancer Screening Tests Market 2021-2025

  • Report
  • February 2021
  • 120 Pages
  • Global
From
From
From
  • 8 Results (Page 1 of 1)
Loading Indicator

In Vitro Colorectal Cancer Screening Tests are a type of In Vitro Diagnostics (IVD) used to detect colorectal cancer in individuals. These tests are typically performed on a sample of stool, which is then analyzed for the presence of certain biomarkers associated with colorectal cancer. The most common type of test is the fecal immunochemical test (FIT), which detects the presence of human hemoglobin in the stool. Other tests include the fecal occult blood test (FOBT), which detects the presence of blood in the stool, and the stool DNA test, which detects the presence of mutated DNA in the stool. The In Vitro Colorectal Cancer Screening Tests market is a rapidly growing segment of the IVD market, driven by increasing awareness of the importance of early detection of colorectal cancer. The market is expected to continue to grow in the coming years, as more countries adopt screening programs and as new technologies are developed. Some of the major companies in the In Vitro Colorectal Cancer Screening Tests market include Roche Diagnostics, Abbott Laboratories, Becton Dickinson, Siemens Healthineers, and Quest Diagnostics. Show Less Read more